Peerbolte Tessa F, van Diggelen Rozanne Ja, van den Haak Pieter, Geurts Kim, Evers Luc Jw, Bloem Bastiaan R, de Vries Nienke M, van den Berg Sanne W
Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
Department Human Movement Sciences, University Medical Center Groningen, Groningen, The Netherlands.
J Med Internet Res. 2025 Aug 26;27:e72309. doi: 10.2196/72309.
Conversational agents (CAs) are increasingly used as a promising tool for scalable, accessible, and personalized self-management support of people with a chronic disease. Studies of CAs for self-management of chronic disease operate within a multidisciplinary domain: self-management originates from (behavioral) psychology and CAs stem from intervention technology, while diseases are typically studied within the biomedical context. To ensure their effectiveness, structured evaluations and descriptions of the interventions, integrating biomedical, behavioral, and technological perspectives, are essential.
We aimed to examine the design and evaluation of CAs for self-management support of chronic diseases, focusing on their characteristics, integration of behavioral change techniques, and evaluation methods. The findings will guide future research and inform intervention design.
We conducted a systematic search in the PubMed and Embase databases to identify studies that investigated CAs for chronic disease self-management, published from January 1, 2018, to April 15, 2024. Full-text journal articles, published in English, studying the efficacy or effectiveness of a CA in the context of self-management for chronic diseases in adults were included. Data extraction was guided by conceptual frameworks to ensure comprehensive reporting of intervention and methodologies: the behavioral intervention technology model and the CONSORT-EHEALTH (Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth) checklist. Risk of bias was assessed using the Risk of Bias 2 tool and the Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) tool (version 2).
In total, 25 studies were included, primarily focusing on text-based, rule-based CAs delivered via a mobile apps. The chronic diseases predominantly targeted were diabetes and cancer. Commonly identified clusters of behavior change techniques were "shaping knowledge," "feedback and monitoring," "natural consequences," and "associations." However, reporting of behavior change techniques and their delivery was lacking, and intervention descriptions were limited. Studies were mostly in the early phase, with a great variety in intervention descriptions, study methods, and outcome measures.
Advancing the field of CA-based interventions requires transparent intervention descriptions, rigorous methodologies, consistent use of validated scales, standardized taxonomy, and reporting aligned with standardized frameworks. Enhanced integration of artificial intelligence-driven personalization and a focus on implementation in health care settings are critical for future research.
对话代理(CAs)越来越多地被用作一种有前景的工具,为慢性病患者提供可扩展、可及且个性化的自我管理支持。针对慢性病自我管理的对话代理研究在一个多学科领域内开展:自我管理源自(行为)心理学,而对话代理源于干预技术,同时疾病通常在生物医学背景下进行研究。为确保其有效性,整合生物医学、行为学和技术学视角对干预措施进行结构化评估和描述至关重要。
我们旨在研究用于慢性病自我管理支持的对话代理的设计与评估,重点关注其特征、行为改变技术的整合以及评估方法。研究结果将为未来研究提供指导并为干预设计提供参考。
我们在PubMed和Embase数据库中进行了系统检索,以识别2018年1月1日至2024年4月15日期间发表的关于研究对话代理用于慢性病自我管理的研究。纳入以英文发表的、研究对话代理在成人慢性病自我管理背景下的疗效或有效性的全文期刊文章。数据提取以概念框架为指导,以确保对干预措施和方法进行全面报告:行为干预技术模型和CONSORT-EHEALTH(电子和移动健康应用及在线远程医疗试验报告统一标准)清单。使用偏倚风险2工具和非随机干预研究中的偏倚风险(ROBINS-I)工具(第2版)评估偏倚风险。
总共纳入25项研究,主要关注通过移动应用程序提供的基于文本、基于规则的对话代理。主要针对的慢性病是糖尿病和癌症。常见的行为改变技术集群包括“塑造知识”“反馈与监测”“自然结果”和“关联”。然而,行为改变技术及其实施方式的报告不足,干预描述有限。研究大多处于早期阶段,干预描述、研究方法和结局测量差异很大。
推进基于对话代理的干预领域需要透明的干预描述、严谨的方法、一致使用经过验证的量表、标准化的分类法以及与标准化框架一致的报告。加强人工智能驱动的个性化整合并关注在医疗保健环境中的实施对未来研究至关重要。